Infinity Pharmaceuticals Inc. (NASDAQ:INFI) announced that clinical data from its IPI-549 Phase 1/1b study was selected as a late-breaking abstract and will be presented on …
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) saw its shares crater by as much as 62% today on exceptionally high volume. This drop was triggered by …
Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX) Ortho Dermatologics division announced results from the Pivotal Phase 3 long-term extension study (AMAGINE-2), which demonstrated that SILIQ™ (brodalumab) …
Tenapanor is a viable drug in the treatment of IBS-C, says Cantor’s Mara Goldstein.
Trevena Inc (NASDAQ:TRVN) shares are tumbling nearly 16% to $1.98 in after-hours trading Wednesday, after the biopharmaceutical company announced that the development of …
Bioblast Pharma Ltd (NASDAQ:ORPN) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 54% …
No surprises within Rhopressa briefing documents – Good news for Aerie investors.
Celsion Corporation (NASDAQ:CLSN) shareholders are stoked in anticipation for tomorrow’s R&D Day conference set in New York City, with shares experiencing a just …
A heavy-hitter catalyst is about to go up to bat for AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a key FDA decision looming in the foreground, …
Dewey Steadman believes Aerie’s Rhopressa is in good standing for Friday’s AdCom.
